Home › Funds › Bridge City Capital, LLC › PCRX

Bridge City Capital, LLC position in PCRX

PACIRA BIOSCIENCES INC · Health Care

Bridge City Capital, LLC reported holding 352,738 shares of PCRX (PACIRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$8.8M, representing 1.84% of its reported portfolio and ranking #11 among its reported holdings. Bridge City Capital, LLC has disclosed PCRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)352.74K sh
Reported value held$8.84M
Portfolio Weight1.84%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Bridge City Capital, LLC's PCRX position evolved

Bridge City Capital, LLC first disclosed a stake in PCRX in Q1 2024 at 61,944 shares (US$1.8M). The position peaked in Q1 2026 at 402,765 shares, worth US$9.1M. Across 11 filings, Bridge City Capital, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 352,738 shares valued at US$8.8M — an increase of 40,441 shares quarter over quarter.. Notable position changes include a 172% increase in Q3 2024 (shares rose 25% over the following quarter), a 84% increase in Q3 2025 (shares were roughly flat over the following quarter), a 41% increase in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 61.94K $1.81M New
Q2 2024 84.86K $2.43M Add
Q3 2024 231.22K $3.48M Add
Q4 2024 229.20K $4.32M Reduce
Q1 2025 172.15K $4.28M Reduce
Q2 2025 169.67K $4.06M Reduce
Q3 2025 311.44K $8.03M Add
Q4 2025 285.49K $7.39M Reduce
Q1 2026 402.76K $9.10M Add
Q2 2026 312.30K $7.92M Reduce
Q3 2026 352.74K $8.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCRX and 13F data

PCRX (PACIRA BIOSCIENCES INC) is a Health Care company. 21 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$87.0M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCRX

All PCRX fund holders →

FAQ

How long has Bridge City Capital, LLC held PCRX?

Bridge City Capital, LLC has disclosed PCRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Bridge City Capital, LLC's current position in PCRX?

As of Q3 2026, Bridge City Capital, LLC holds 352.74K shares of PCRX (PACIRA BIOSCIENCES INC), valued at $8.84M, representing 1.84% of its reported portfolio and ranking #11.

Has Bridge City Capital, LLC been buying or selling PCRX?

In the latest 13F filing (Q3 2026), Bridge City Capital, LLC increased its position in PCRX. The position peaked in Q1 2026 at 402.76K shares.

Which other funds hold PCRX?

Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.